Oliver Schub

Oliver Schub is the Senior Director of Business Development at Icosagen Group. Oliver has previously worked as the Director of Business Development at Navigo Proteins GmbH, and as a Senior Business Development Manager and Business Development Manager at ProBioGen AG.

Oliver has over 10 years of experience in business development in the biotechnology industry. Oliver has a proven track record in developing and executing successful business development strategies, and in building and maintaining relationships with key opinion leaders and decision-makers.

Oliver holds a degree in Biology from the University of Hamburg.

Oliver Schub completed their undergraduate studies at Universität Regensburg, where they earned their diploma in chemistry. Oliver then went on to pursue a PhD in the field of control of human DNA replication by the action of cyclin-dependent kinases (CDK's) at Ludwig-Maximilians Universität München. After completing their PhD, Schub became a postdoctoral researcher in the field of biochemistry at Institut für Molekulare Biotechnologie (IMB) in Jena, Germany, under the supervision of Frank Grosse.

Their manager is Meelis Kadaja, Chief Business Development Officer.